[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$ifrx
$IFRX sees increased social engagement with positive sentiment, especially with the upcoming Phase 2a data on HS and CSU. Investors are watching closely as the project navigates market fluctuations and potential developments ahead, with some analysts suggesting a potential for significant upside if the data is positive.
About $ifrx
A cryptocurrency.
Insights #
- $ifrx sentiment is up XXXXX% from the previous week.
- $ifrx creators is up XXXXX% from the previous week.
- $ifrx mentions is up XXXXX% from the previous week.
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX +0.82%
1 Month: XXXXXX -XX%
1-Year High: XXXXXX on 2025-08-29
1-Year Low: XX on 2025-09-26
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Week: XX +83%
1 Month: XX +61%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-09-21
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $ifrx in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: XX
1 Week: XX +44%
1 Month: XX +13%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-04-27
The most influential creators that mention $ifrx in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXXXX |
| @StreetCred2017 | X | XXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +25%
1 Month: XX% -XX%
1-Year High: XXX% on 2025-04-28
1-Year Low: XX% on 2025-09-24
Most Supportive Themes
- Positive Sentiment: (65%) Enthusiasm for the project's potential and future developments.
Most Critical Themes
- Market Volatility: (35%) Concerns about price fluctuations and market uncertainty.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XX | X% | XXXXX | XX% | XX | X% |
| Total | XX | X% | XXXXX | XX% | XX | X% |
Top assets mentioned In the posts about $ifrx in the last XX hours
Amgen, Inc. (AMGN) Protagonist Therapeutics, Inc (PTGX) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) IDEAYA Biosciences, Inc. Common Stock (IDYA) Movement (MOVE) Hundred Million (100M) Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) ROGin AI (ROG) Zimmer Biomet Holdings Inc (ZBH)
Top topics mentioned In the posts about $ifrx in the last XX hours
stocks healthcare, $amgn, $evax, $lqda, $ptgx, $dcth, $ipdn, $ydes, $mltx, $celc, $idya, move movement, coins made in usa, coins zk, $asnd, $100m, market cap, $4b, acquisition, $ccxi, $gctk, $gmhs, $duo, dont buy, eli lilly, $lly, $rog, investment, $107k, $54k, zimmer biomet holdings inc, atai life, stocks bitcoin treasuries, $atai, $teva, $azn, $alxn, approved, chronic, $slrn, rates, $drug, $ewtx, dyne therapeutics, $dyn, $zura, $abbv, $okra, $nvx, $mp, coins exchange tokens, coins solana ecosystem, $nvts
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $ATAI Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $SVRA Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $INBX Phase X $VOR Phase X $JAGX Phase X $ALXO Phase X $PROK Phase X $VRCA Phase X $KZR Phase 2a $OSTX Phase 2b $ELDN Phase X $IFRX Phase 2a $IFRX Phase 2b $RZLT Phase X $NKTR Phase 2b $PVLA Phase X $PRAX Phase X $ASMB Phase X $RCUS Phase X $ZNTL Phase X $WVE Phase X $VALN Phase X $ROIV Phase X $RYTM Phase X $RXRX Phase X $RAPT Phase X $PRTA Phase X $PCSA Phase X $PRAX Phase 2/3 $MRUS Phase 2"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, 33K engagements
"@Quick2smile @ANKITSH85153215 Interesting and I think Inflarx did same thing w cSCC At end of the day it (C5a antagonist) may wind up being used in combination w some chemo agent. $AMGN $IFRX #PancreaticCancer needs anything that improves XX% survival rates. Compassionate use"
X Link @StreetCred2017 2025-10-06T12:50Z XXX followers, XXX engagements
"@ANKITSH85153215 Friday study showing $AMGN c5aR pathway complement system and soc chemo reduced pancreatic cancer tumor 80%. Big for Avacopan already FDA approved AAV. $IFRX best in c5aR class. #PancreaticCancer very low X yr survival 12%"
X Link @StreetCred2017 2025-10-06T11:09Z XXX followers, XXX engagements
"$AMGN Breaking: Avacopan seen blocking pancreatic cancer tumors over XX% when combined with gemcitabine/nab-paclitaxel (standard PDAC chemo) XX% Avacopan motherly only - looks like way bigger market for C5aR inhibitor market than just AAV supporting $4b buyout $CCXI $IFRX still at a whopping $100m In vivo CCX168 monotherapy reduced tumor volume by XX% (p0.01); combining it with gemcitabine/nab-paclitaxel (standard PDAC chemo) and immune checkpoint inhibitors (pembrolizumab/ipilimumab) achieved the strongest effectsup to XX% tumor reduction increased CD8+ T-cell infiltration (p0.01) and"
X Link @StreetCred2017 2025-10-05T23:47Z XXX followers, XXX engagements